Skip to main content
. 2014 Sep 13;104(1):38–50. doi: 10.1007/s00392-014-0755-6

Table 1.

Baseline characteristics of the examined groups

Hypertensives Normotensives
ACEI HCTZ EPT+ EPT− p
EPT+ EPT− p EPT+ EPT− p
BP measurements
 mSBP (mmHg) 161.2 ± 9.6* 162.2 ± 9.8* NS 159.7 ± 7.6* 160.4 ± 9.0* NS 136.2 ± 2.5 136.5 ± 3.0 NS
 mDBP (mmHg) 97.8 ± 2.4* 98.9 ± 3.1* NS 97.1 ± 2.7* 98.4 ± 3.5* NS 85.0 ± 2.6 85.6 ± 2.6 NS
 mSBP24 (mmHg) 149.2 ± 6.3* 148.1 ± 6.9* NS 149.0 ± 6.1* 148.5 ± 7.0* NS 129.4 ± 2.7 129.9 ± 2.6 NS
 mDBP24 (mmHg) 92.5 ± 1.5* 92.8 ± 1.9* NS 92.7 ± 1.6* 92.9 ± 1.6* NS 82.9 ± 2.3 83.6 ± 2.3 NS
 Fall SBP24 (%) 7.0 ± 2.6* 7.1 ± 3.1* NS 7.0 ± 2.2* 7.8 ± 3.2* NS 9.9 ± 1.9 9.9 ± 1.9 NS
 Fall DBP24 (%) 6.2 ± 1.8* 5.9 ± 1.8* NS 6.4 ± 2.0* 6.5 ± 2.4* NS 10.1 ± 2.1 10.6 ± 2.7 NS
Metabolic parameters
Lipid profile
 Total cholesterol (mmol/L) 5.9 ± 0.4 6.0 ± 0.4 NS 5.8 ± 0.5 6.0 ± 0.4 NS 5.9 ± 0.5 5.8 ± 0.4 NS
 LDL cholesterol (mmol/L) 3.7 ± 0.5 3.9 ± 0.4 NS 3.7 ± 0.5 3.9 ± 0.4 NS 3.8 ± 0.5 3.7 ± 0.4 NS
 HDL cholesterol (mmol/L) 1.4 ± 0.1 1.4 ± 0.1 NS 1.4 ± 0.1 1.4 ± 0.1 NS 1.4 ± 0.1 1.3 ± 0.1 NS
 Triglycerides (mmol/L) 1.7 ± 0.1 1.7 ± 0.1 NS 1.7 ± 0.1 1.7 ± 0.2 NS 1.6 ± 0.2 1.7 ± 0.1 NS
 Glucose (mmol/L) 5.3 ± 0.6 5.5 ± 0.6 NS 5.2 ± 0.6 5.5 ± 0.6 NS 5.4 ± 0.6 5.3 ± 0.6 NS
 Insulin (µI/L) 19.1 ± 6.4* 19.7 ± 7.3* NS 19.6 ± 4.8* 20.3 ± 7.8* NS 16.4 ± 5.1 17.0 ± 6.4 NS
 Uric acid (mg/dL) 6.2 ± 2.1* 6.2 ± 2.0* NS 6.2 ± 1.6* 6.4 ± 2.1* NS 5.0 ± 1.4 5.0 ± 1.2 NS
Hemodynamic parameters
 PWV (m/s) 10.7 ± 1.7* 10.8 ± 1.4* NS 10.8 ± 1.6* 10.8 ± 2.1* NS 8.9 ± 1.5 8.6 ± 1.1 NS
 RPF (mL/min) 421.9 ± 81.1* 423.7 ± 74.2* NS 426.3 ± 66.0* 423.0 ± 75.1* NS 488.7 ± 47.3 496.6 ± 45.0 NS
 GFR (mL/min) 105.9 ± 7.5* 104.7 ± 7.7* NS 106.9 ± 5.8* 105.2 ± 5.7* NS 115.1 ± 5.2 114.8 ± 5.9 NS

mSBP/mDBP mean systolic/diastolic blood pressure in office measurement, mSBP 24 /mDBP 24 mean systolic/diastolic blood pressure in 24-hour ambulatory monitoring, Fall SBP 24 /Fall DBP 24 day-night fall of systolic/diastolic blood pressure in 24-hour ambulatory monitoring

* p < 0.05–0.0001 values that are, at baseline, significantly different in comparison to hypertensives ACEI (EPT+; EPT−) and HCTZ (EPT+; EPT−) vs. normotensives (EPT+; EPT), respectively